Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P(1)(') group.
Research paper by Philippe G PG Nantermet, James C JC Barrow, Stacey R SR Lindsley, MaryBeth M Young, Shi-Shan SS Mao, Steven S Carroll, Carolyn C Bailey, Michele M Bosserman, Dennis D Colussi, Daniel R DR McMasters, Joseph P JP Vacca, Harold G HG Selnick
Indexed on: 15 Apr '04Published on: 15 Apr '04Published in: Bioorganic & Medicinal Chemistry Letters
Join Sparrho today to stay on top of science
Discover, organise and share research that matters to you
Join Sparrho today to stay on top of science
Discover, organise and share research that matters to you
Join for free
Abstract
Structural modifications of the aminopyridine P(1)(') group of imidazole acetic acid based TAFIa inhibitors led to the discovery of the aminocyclopentyl analog 28, a 1 nM TAFIa inhibitor with CLT(50) functional activity of 14 nM but without selectivity against CPB. While not as active, aminobutyl derivative 27 provided an improved 6.7-fold selectivity for TAFIa versus CPB.